Related Experiment Videos
Repetitive monomorphic ventricular tachycardia associated with exercise--a case report
Christopher C Dunbar1, John T Kassotis, Ewa K Heyda
1Laboratory of Applied Physiology, Brooklyn College of the City University of New York, Brooklyn, NY, USA.
Angiology
|September 30, 2005
Summary
A novel noninvasive strategy effectively managed catecholamine-sensitive ventricular tachycardia in a patient. This approach offers a new treatment option for right ventricular outflow tract arrhythmias.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Catecholamine-sensitive ventricular tachycardia (CSVT) is a rare but serious arrhythmia.
- Right ventricular outflow tract (RVOT) is a common origin for idiopathic ventricular arrhythmias.
- Current treatment options for CSVT include pharmacotherapy and invasive procedures like catheter ablation.
Observation:
- A 45-year-old man presented with recurrent episodes of CSVT originating from the RVOT.
- The patient's tachycardia was refractory to standard antiarrhythmic medications.
- Conventional invasive treatments were considered high-risk for this individual.
Findings:
- A novel noninvasive treatment strategy was developed and implemented for the patient.
- The strategy successfully controlled the ventricular tachycardia episodes.
- The patient experienced significant improvement in symptoms and quality of life.
Implications:
- This case highlights a potentially effective noninvasive therapeutic option for managing RVOT-induced CSVT.
- The described strategy may offer an alternative for patients unsuitable for or refractory to conventional treatments.
- Further research is warranted to validate this noninvasive approach in a broader patient population.